Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300281
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,137
Award facts
- Contract value 100% obligated
- $14,136.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, was awarded a $14,136.80 firm fixed price contract by the Office of the Director on October 17, 2014, with an ultimate completion date of February 28, 2015. This contract was issued as a call under an existing Blanket Purchase Agreement (BPA) and carries no set-aside designation. The contract covers drugs and biologicals to be delivered to Rockford, Illinois.
As a child entity of Thermo Electron Corporation's Financial Services Division, Pierce Biotechnology brought established expertise in supplying scientific instruments and laboratory equipment to federal agencies. Thermo Electron, through its various subsidiaries and operating divisions, maintains a significant federal contracting presence serving agencies including the Department of Health and Human Services, Department of Defense, and Environmental Protection Agency. The parent company's portfolio includes mass spectrometers, chromatography systems, spectroscopy instruments, and related analytical equipment, positioning this award within the company's broader market of providing specialized scientific and diagnostic solutions to government customers.
Quick answers
Who was awarded contract HHSN26300281?
HHSN26300281 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on October 17, 2014.
How much is contract HHSN26300281 worth?
The government has obligated $14,137 on HHSN26300281.
Is contract HHSN26300281 an order under another contract?
Yes. HHSN26300281 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300281 competed?
The extent of competition for HHSN26300281 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award